New insights and modern treatment of AL amyloidosis

CP Chaulagain, RL Comenzo - Current hematologic malignancy reports, 2013 - Springer
Systemic amyloidosis is a rare disease that is rarely cured. Systemic immunoglobulin light-
chain amyloidosis (AL) is the most common type, usually the result of monoclonal light …

New insights and modern treatment of AL amyloidosis

CP Chaulagain, RL Comenzo - Current hematologic …, 2013 - pubmed.ncbi.nlm.nih.gov
Systemic amyloidosis is a rare disease that is rarely cured. Systemic immunoglobulin light-
chain amyloidosis (AL) is the most common type, usually the result of monoclonal light …

New Insights and Modern Treatment of AL Amyloidosis

CP Chaulagain, RL Comenzo - Current Hematologic Malignancy Reports, 2013 - infona.pl
Systemic amyloidosis is a rare disease that is rarely cured. Systemic immunoglobulin light-
chain amyloidosis (AL) is the most common type, usually the result of monoclonal light …

[引用][C] New Insights and Modern Treatment of AL Amyloidosis

CP Chaulagain, RL Comenzo - Current Hematologic Malignancy …, 2013 - cir.nii.ac.jp
New Insights and Modern Treatment of AL Amyloidosis | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

[PDF][PDF] New Insights and Modern Treatment of AL Amyloidosis

CP Chaulagain, RL Comenzo - 2013 - researchgate.net
Systemic amyloidosis is a rare disease that is rarely cured. Systemic immunoglobulin light-
chain amyloidosis (AL) is the most common type, usually the result of monoclonal light …

New insights and modern treatment of AL amyloidosis.

CP Chaulagain, RL Comenzo - Current Hematologic Malignancy …, 2013 - europepmc.org
Systemic amyloidosis is a rare disease that is rarely cured. Systemic immunoglobulin light-
chain amyloidosis (AL) is the most common type, usually the result of monoclonal light …